Abstract
Background: The efficacy and safety of 6-mercaptopurine (6-MP) therapy rely on the concentration of its metabolites. The aim of the current study is the pharmacokinetic analysis of 6-MP and the detection of its metabolites as well as the role of Thiopurine S-methyl transferase (TPMT), the enzyme associated with 6-MP metabolism, as a pharmacogenomics biomarker.
Cite
CITATION STYLE
APA
Sivolapenko, G. (2015). A Pharmacokinetic Analysis and Pharmacogenomic Study of 6-mercaptopurine. International Journal of Pharmaceutical Sciences and Developmental Research, 002–007. https://doi.org/10.17352/ijpsdr.000002
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free